![]() ![]() Learn more about digital innovation in Flanders. “This will help expand our reach and identify the 936 million people around the globe who have sleep apnea.” “Ectosense’s digital and easy-to-use solutions can help significantly increase diagnoses, as well as general awareness of this highly prevalent, 100% treatable disease,” asserts Jim Hollingshead, ResMed President of Sleep and Respiratory Care. I can clearly see in the graph when I forget to put. If you get no indication for various nights, congratulations you do not have sleeping apnea. So in the morning you can see if you had some or many drops in O2 level, indicating a serious issue. “Ectosense’s home sleep apnea test enables us to help millions of people improve their overall health.” Jim Hollingshead, ResMed President of Sleep and Respiratory Care The ring monitors and records the oxygen level in blood throughout the night. Now that the deal is finalized, ResMed shares its ambitions. To acquire Ectosense, ResMed had to buy out a local and a British investment fund, as well as imec, Ectosense’s founders, and some private investors. To fully utilize the potential, ResMed decided to upgrade its minority share into a complete acquisition. Important to know: NightOwl is commercialized in the US as well, where it was approved by the US Food & Drug Administration (FDA), opening up an enormous market. The first markets were India, New Zealand, and Australia, while people in several European countries also have access to the test. ResMed started distributing the cloud-connected home sleep apnea test in 2020 under the name onesleeptest. This swift detection method is a first step in giving millions of people a better night’s sleep, because once detected, apnea can be treated with a special pressure mask or a mouth brace. How does NightOwl work? The idea is as simple as it is ingenious: you place a small piece of medical equipment on your forehead or fingertip, you go to sleep, and in the morning a mobile app tells you if treatment is necessary by means of a report on, among other things, your respiration and oxygen saturation. ![]() First step towards a better night’s sleep ResMed already had a minority share since last year, but now takes full control. The NightOwl test by Ectosense, a spin-off company of strategic research center imec in Flanders, is a game changer because of its ability to detect sleep apnea in one night. Around the world, more than 900 million people suffer from sleep apnea – many of whom remain undiagnosed.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |